Over the past 12 months, 9 insiders at Edwards Lifesciences Corp filed 44 open-market SEC Form 4 transactions on EW: 0 purchases worth $0 and 44 sales worth $22.5M. Insiders have been net sellers over this period. The most recent filing was on Jul 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 26 | Bernard J ZovighianCEO, Director | SELL | 2.9K | $83.93 | $245K |
| Jul 10, 26 | Daniel J. LippisCVP, TAVR | SELL | 619 | $91.70 | $57K |
| Jun 30, 26 | Daniel J. LippisCVP, TAVR | SELL | 619 | $91.40 | $57K |
| Jun 17, 26 | Bernard J ZovighianCEO | SELL | 523 | $87.92 | $46K |
| May 29, 26 | Andrew M. DahlSVP, Corporate Controller | SELL | 568 | $86.08 | $49K |
| May 27, 26 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 23.1K | $86.42 | $2.0M |
| May 22, 26 | Daveen ChopraCVP, TMTT & Surgical | SELL | 1.5K | $84.60 | $127K |
| May 18, 26 | Daniel J. LippisCVP, TAVR | SELL | 620 | $81.14 | $50K |
| May 15, 26 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 10.0K | $82.07 | $818K |
| May 12, 26 | Bernard J ZovighianCEO | SELL | 35.5K | $78.40 | $2.8M |
| May 11, 26 | Wayne MarkowitzCVP, JAPAC | SELL | 593 | $79.73 | $47K |
| May 4, 26 | Daniel J. LippisCVP, TAVR | SELL | 1.0K | $83.98 | $86K |
| May 1, 26 | Daniel J. LippisCVP, TAVR | SELL | 1.0K | $83.99 | $83K |
| Apr 9, 26 | Scott B. UllemCVP, Chief Financial Officer | SELL | 8.3K | $80.50 | $664K |
| Apr 6, 26 | Daniel J. LippisCVP, TAVR | SELL | 1.0K | $80.98 | $83K |
| Mar 11, 26 | Daniel J. LippisCVP, TAVR | SELL | 1.0K | $85.38 | $87K |
| Mar 11, 26 | Scott B. UllemCVP, Chief Financial Officer | SELL | 7.9K | $85.21 | $673K |
| Mar 2, 26 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 11.3K | $85.93 | $974K |
| Feb 25, 26 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 24.0K | $83.84 | $2.0M |
| Feb 12, 26 | Bernard J ZovighianCEO | SELL | 19.9K | $77.13 | $1.5M |
| Jan 9, 26 | Daniel J. LippisCVP, TAVR | SELL | 1.0K | $85.70 | $87K |
| Jan 6, 26 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 8.7K | $85.98 | $749K |
| Dec 12, 25 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 5.9K | $83.79 | $494K |
| Dec 12, 25 | Daniel J. LippisCVP, JAPAC | SELL | 1.0K | $84.03 | $86K |
| Dec 12, 25 | Heisz Leslie StoneDirector | SELL | 2.6K | $83.41 | $218K |
| Dec 11, 25 | Daveen ChopraCVP, TMTT & Surgical | SELL | 2.0K | $84.38 | $169K |
| Dec 10, 25 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 11.3K | $83.83 | $951K |
| Dec 10, 25 | Bernard J ZovighianCEO | SELL | 3.9K | $83.45 | $322K |
| Dec 9, 25 | Scott B. UllemCVP, Chief Financial Officer | SELL | 7.7K | $84.47 | $650K |
| Dec 8, 25 | Wayne MarkowitzCVP, JAPAC | SELL | 583 | $86.01 | $50K |
| Dec 8, 25 | Bernard J ZovighianCEO | SELL | 21.5K | $85.21 | $1.8M |
| Nov 10, 25 | Daniel J. LippisCVP, JAPAC | SELL | 1.0K | $82.55 | $84K |
| Nov 10, 25 | Scott B. UllemCVP, Chief Financial Officer | SELL | 10.0K | $83.30 | $832K |
| Aug 25, 25 | Daveen ChopraCVP, TMTT | SELL | 2.5K | $81.95 | $205K |
| Aug 18, 25 | Larry L WoodGlobal President TAVR & Surg | SELL | 8.9K | $78.06 | $699K |
| Jul 28, 25 | Daniel J. LippisCVP, JAPAC | SELL | 4.1K | $79.46 | $327K |
| Jun 16, 25 | Larry L WoodGlobal President TAVR & Surg | SELL | 8.9K | $75.23 | $673K |
| Jun 3, 25 | Bernard J ZovighianCEO | SELL | 967 | $77.32 | $75K |
| Jun 2, 25 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 2.6K | $77.40 | $199K |
| May 30, 25 | Bernard J ZovighianCEO | SELL | 16.1K | $77.21 | $1.2M |
| May 22, 25 | Daveen ChopraCVP, TMTT | SELL | 1.5K | $75.08 | $113K |
| May 9, 25 | Daniel J. LippisCVP, JAPAC | SELL | 330 | $74.42 | $25K |
| May 9, 25 | Scott B. UllemCVP, Chief Financial Officer | SELL | 11.3K | $74.40 | $837K |
| May 7, 25 | Wayne MarkowitzGM & SVP, Surgical | SELL | 268 | $75.08 | $20K |
| May 5, 25 | Bernard J ZovighianCEO | SELL | 6.0K | $74.91 | $448K |
| Apr 14, 25 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 9.5K | $69.81 | $663K |
| Apr 8, 25 | Daniel J. LippisCVP, JAPAC | SELL | 300 | $70.61 | $21K |
| Mar 26, 25 | Scott B. UllemCVP, Chief Financial Officer | SELL | 11.3K | $70.87 | $797K |
| Mar 13, 25 | Donald E Bobo JrCVP,Strategy/Corp Development | SELL | 9.5K | $67.96 | $646K |
| Mar 10, 25 | Daniel J. LippisCVP, JAPAC | SELL | 400 | $69.48 | $28K |
Over the past 12 months, insiders at Edwards Lifesciences Corp filed 0 open-market purchases worth $0 and 44 sales worth $22.5M on EW, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 27, 26.
9 different insiders at Edwards Lifesciences Corp filed open-market SEC Form 4 transactions on EW over the last 12 months.
InsiderTape plots every EW insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Edwards Lifesciences Corp insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →